Primary Category:
Treatment Protocols
Disease Category:
Pancreatic, Pancreatic Metastatic
Status:
Open
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations
NCT#04548752
S2001 is reopened to accrual with the implementation of Revision 4, effective April 18, 2023.
